Loading company…
Xinhenglu Medical Technology develops intelligent micro-physiological organoid systems for precision medicine and drug development.
Founded in 2025 and based in Shanghai, Xinhenglu Medical Technology focuses on intelligent micro-physiological organoid systems. It combines organoid technology with automation and AI for precision medicine and new drug development. In January 2026, the company raised venture funding from K2VC.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Xinhenglu Medical Technology (Shanghai) Co., Ltd.? This is my company